Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAPK3 |
| Upstream (Parents) |
|---|
| (<<) ADRBK1 → MAPK3 |
| (<<) BCL2L1 → MAPK3 |
| (<<) CRTC1 → MAPK3 |
| (<<) CYB5R3 → MAPK3 |
| (<<) GNAI2 → MAPK3 |
| (<<) GNB2 → MAPK3 |
| (<<) HNF1A → MAPK3 |
| (<<) JUND → MAPK3 |
| (<<) MAP2K2 → MAPK3 |
| (<<) MAP3K10 → MAPK3 |
| (<<) PIP5K1C → MAPK3 |
| (<<) PLD3 → MAPK3 |
| (<<) PRSS36 → MAPK3 |
| (<<) RARG → MAPK3 |
| (<<) SF3A2 → MAPK3 |
| (<<) SH3GLB2 → MAPK3 |
| (<<) SPPL2B → MAPK3 |
| (<<) TGFB1 → MAPK3 |
| (<<) VEGFB → MAPK3 |
| Downstream (Children) |
|---|
| MAPK3 → ALDOA (>>) |
| MAPK3 → ARAF (>>) |
| MAPK3 → DLGAP3 (>>) |
| MAPK3 → DNAJA1 (>>) |
| MAPK3 → ERBB3 (>>) |
| MAPK3 → FLJ22184 (>>) |
| MAPK3 → GNRH2 (>>) |
| MAPK3 → HDAC5 (>>) |
| MAPK3 → HDAC6 (>>) |
| MAPK3 → HPS6 (>>) |
| MAPK3 → INPPL1 (>>) |
| MAPK3 → ITGA3 (>>) |
| MAPK3 → MYH14 (>>) |
| MAPK3 → NDOR1 (>>) |
| MAPK3 → NRSN2 (>>) |
| MAPK3 → PAK4 (>>) |
| MAPK3 → PCSK1N (>>) |
| MAPK3 → PDK2 (>>) |
| MAPK3 → PPP1R11 (>>) |
| MAPK3 → PRKACA (>>) |
| MAPK3 → PRKCSH (>>) |
| MAPK3 → RHOQ (>>) |
| MAPK3 → RHOT2 (>>) |
| MAPK3 → RXRA (>>) |
| MAPK3 → SH3GL1 (>>) |
| MAPK3 → SULT1A1 (>>) |
| MAPK3 → VAC14 (>>) |
| MAPK3 → WDR36 (>>) |
